Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A randomized, double-blind, cross-over, 4-period, 4 treatment, within-subject placebo-controlled study to assess the optimal renoprotective dose of Aliskiren in hypertensive type 2 diabetes patients with incipient or overt nephropathy https://kusajili.com:443/Trial/NA_mbEytKESXil0Sw_SCMA%24a-randomized-double-blind-cross-over-4-period-4-treatment-within-subject-placebo-controlled-study-to-assess-the-optimal-renopro
I have read and accept the terms of use of the site and the Privacy Policy
Send your message